Tag: FDA-, LOSS

3-year-old patients did not differ from 4-year-olds in terms of ability to perform or complete testing

Findings based on smartphone home videos from children younger than 2 years

taVNS significantly reduces insomnia severity and is associated with sustained benefits over 20 weeks

In men, nearly 50 percent of esophageal cancer deaths and DALYs attributable to tobacco use in 2019

Decreasing trends in performance of bystander CPR, AED use, ROSC seen with minority status, poverty levels

Vitamin D supplementation, with or without calcium, offers no benefit for preventing falls or fractures in community-dwelling seniors

First-attempt success significantly higher in intervention group receiving expert intubation coaching on a manikin

Patients with an alert more likely to have serum lactate tested and intravenous fluid ordered

Empagliflozin may lower risk for diabetic retinopathy progression

β-blocker use also tied to reduced rate of worsening of symptoms in early motor-manifest disease

No change seen in knowledge of the association from 2018 to 2020 among adults, focusing on those aged 27 to 45 years

MS-polygenic risk score and household parental smoking negatively linked to total brain volume, thalamic volume

Review shows lower risk with moderate alcohol consumption and eating fruits and cereals, with moderate certainty of evidence

Analysis of Maryland case load during June 2023 Western Canadian fires reveals increases in clinical encounters for cardiopulmonary disease

Risk for PSE was lower for patients treated with ARBs and higher for those receiving calcium channel blockers, beta-blockers